Literature DB >> 8369066

Screening for ovarian cancer. Other chronic diseases affect serum marker.

P Tambyah, I Yap, W C Lye.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8369066      PMCID: PMC1678108          DOI: 10.1136/bmj.306.6893.1684-a

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  3 in total

1.  Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography.

Authors:  I Jacobs; A P Davies; J Bridges; I Stabile; T Fay; A Lower; J G Grudzinskas; D Oram
Journal:  BMJ       Date:  1993-04-17

2.  CA-125 concentrations in malignant and nonmalignant disease.

Authors:  E Daoud; G Bodor
Journal:  Clin Chem       Date:  1991-11       Impact factor: 8.327

3.  Cancer antigen 125 in serum and ascitic fluid of patients with liver diseases.

Authors:  R Molina; X Filella; J Bruix; P Mengual; J Bosch; X Calvet; J Jo; A M Ballesta
Journal:  Clin Chem       Date:  1991-08       Impact factor: 8.327

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.